idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
04.03.2020 10:42

New platform for cancer diagnostics and drug testing

Press contact, Sahlgrenska Academy, University of Gothenburg, press@sahlgrenska.gu.se Kommunikationsavdelningen / Communications Department
Schwedischer Forschungsrat - The Swedish Research Council

    Parts of tumor tissue, which is normally discarded in cancer surgery, bear information about the disease. So far, as studies at the University of Gothenburg show, this has been unexploited. This research forms the basis for a new experimental platform for cancer diagnostics, prognoses and testing cancer drugs.

    The study published by the research group to date, in the journal Biomaterials, relates to breast cancer. Ongoing studies of colon, ovarian and other cancers also show positive results for the new technological platform and strategy.

    In traditional cancer diagnostics, tumor cells in the extracted tissue are the targets of investigation. Depending on the form of cancer involved, more or less extensive molecular analyses and investigations of prognostic markers are performed.

    For the patients with breast cancer in the current study, this was carried out routinely. The scientists then proceeded to apply the new technology, in cases where tumor tissue that had been removed was still available for them to analyze. Instead of looking at tumor cells, they studied the supporting structure (the “extracellular matrix”, ECM). This is composed partly of protein fibers around the cells and determining the structure of the tissue, like a kind of scaffold for tumor cells.

    Relapses predictable

    Anders Ståhlberg, Associate Professor of Molecular Medicine, is one of the two people primarily responsible for the study and platform.

    “Normally,” he says, “we investigate tumor cells and get rid of the rest. Here, we do the reverse. What we look at are the extracellular matrices, and early on we found major differences among tumors from different patients. These differences were discoverable only from analyses of the ECMs.”

    The scientists were able, for instance, to predict the risk of a recurrence of breast cancer, by studying the properties of the ECMs in various patients’ tissues. This was done by allowing cancer cell lines to grow in the matrices and then analyze how the scaffold affects them.

    Göran Landberg, Professor of Pathology, is the other driving force for the research.

    “Our results have clear connections with clinical parameters, such as how aggressive a tumor is. We’re now working on finding out which parts of the ECMs affected specific cancer-specific properties. The technology works, and we’ve been able to show that this is a superb experimental platform with major clinical potential,” he says.

    Drug testing

    Besides diagnostics and prognoses for the course of a cancer disease, the scientists see drug testing as an important area for the new platform. A drug candidate can then be tested in several individuals’ surgically removed tissue, to explore its potential efficacy in various patients with cancer.

    The purpose of the model is to ascertain which patients will benefit from a treatment before it is commenced. Another advantage is that the use of animal testing can decrease.Göran Landberg and Anders Ståhlberg belong to Sahlgrenska Academy, University of Gothenburg, and the Wallenberg Centre for Molecular and Translational Medicine. A key partner in the study is the state-owned Rise, Research Institutes of Sweden AB.


    Wissenschaftliche Ansprechpartner:

    Contact:

    Professor Göran Landberg, University of Gothenburg, goran.landberg@gu.se

    Associate Professor Anders Ståhlberg, University of Gothenburg, tel. +46 (0)734 22 84 46, anders.stahlberg@gu.se


    Originalpublikation:

    Title: Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment;


    Weitere Informationen:

    https://www.sciencedirect.com/science/article/pii/S0142961219308233


    Bilder

    Merkmale dieser Pressemitteilung:
    Journalisten
    Medizin
    überregional
    Forschungsergebnisse
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).